Search Results 1041-1050 of 18583 for Relapse

  1. Publications - Javier L. Munoz, M.D., M.B.A. - Mayo Clinic

    ... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Gaulin C ...

  2. Ricardo D. Parrondo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Expertise in management of relapsed/refractory plasma cell dyscrasias; Development of early and late-phase clinical trials for plasma cell dyscrasias ...

  3. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory ...

  4. Treating pediatric patients with primary and recurrent rhabdomyosarcoma - Mayo Clinic

    ... , Mayo Clinic treats pediatric patients with primary and recurrent rhabdomyosarcoma, offering a cutting-edge treatment option for relapsed disease.

  5. Publications - Patrick B. Johnston, M.D., Ph.D. - Mayo Clinic

    ... Relapsed/Refractory Non-Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk ... Incidence of Central Nervous System Relapse in Primary Mediastinal Large B ...

  6. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

    ... relapse prevention. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  7. A Study Using Risk Factors To Determine Treatment For Children With Favorable Histology Wilms Tumors (FHWT) - Mayo Clinic

    ... relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk ...

  8. Mayo Clinic Q and A: What is bariatric surgery?

    While these options are effective for some patients, weight relapse is a concern, especially if utilized in high-risk patients with obesity. The most ...

  9. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  10. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...